Finger length clue to motor neurone disease (BBC News Online, 10 May 2011)

Astellas Pharma and Medivation announce initiation of phase 2 clinical trial of MDV3100 in hormone-naive prostate cancer patients (Biospace, 5 May 2011)

Afinitor (Everolimus) for rare pancreatic cancer approved by FDA (Medical News Today, 8 May 2011)

10 May 2011

A new drug for patients with progressive neuroendocrine tumours of the pancreas has been approved by the FDA. Afinitor (everolimus), is a treatment for patients whose pancreatic tumour cannot be surgically removed or where the cancer has metastasised.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read